Form 6-K Elevra Lithium Ltd For: Oct 16
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- US futures steady as oil retreats ahead of earnings deluge, Fed decision
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Why Goldman Sachs expects Fed to skip October rate hike
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2026
Commission File Number 001-42819
ELEVRA LITHIUM LIMITED
(Translation of registrant’s name into English)
Level 3,
10 Eagle Street
Brisbane, Queensland 4000
Australia
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
|
Form 20-F ☒
|
|
Form 40-F ☐
|
Elevra Lithium Limited (the “Registrant”) is furnishing the following exhibits on this Report on Form 6-K, each of which is hereby incorporated by reference:
Exhibit
|
No.
|
Description
|
|
2026 Notice of Annual General Meeting & Explanatory Notes, filed by the Registrant with the Australian Securities Exchange on October 16, 2026.
|
|
|
Announcement filed by the Registrant with the Australian Securities Exchange on October 16, 2026 – Elevra Announced Planned Board Transition.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
ELEVRA LITHIUM LIMITED
|
||
|
Date: October 16, 2026
|
By:
|
/s/ Dylan Roberts
|
|
Name: Dylan Roberts
|
||
|
Title: Company Secretary and General Counsel
|
||
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Elevra Lithium September 2026 Quarterly Report Advisory
- PharmaEssentia to Present Early-Stage Pipeline Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting, Highlighting Immuno-Oncology Approaches for Solid Tumors
- Aisle Launches Tasks, Turning Its 4.4M Shopper Network Into an On-Demand Workforce for In-Store Execution
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
